Vitamin D in Clinical Medicine. Группа авторов

href="#ulink_359b193f-dbb8-565b-bbb8-470932da80a6">18Delanghe JR, Speeckaert R, Speeckaert MM: Behind the scenes of vitamin D binding protein: more than vitamin D binding. Best Pract Res Clin Endocrinol Metab 2015;29:773–786.

19Safadi FF, Thornton P, Magiera H, Hollis BW, Gentile M, Haddad JG, et al: Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest 1999;103:239–251.

20Yamamoto N, Homma S: Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes. Proc Natl Acad Sci USA 1991;88:8539–8543.

21Lauridsen AL, Vestergaard P, Nexo E: Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin Chem 2001;47:753–756.

22Henderson CM, Lutsey PL, Misialek JR, Laha TJ, Selvin E, Eckfeldt JH, et al: Measurement by a novel LC-MS/MS methodology reveals similar serum concentrations of vitamin D-binding protein in blacks and whites. Clin Chem 2016;62:179–187.

23Bolland MJ, Grey AB, Ames RW, Horne AM, Mason BH, Wattie DJ, et al: Age-, gender-, and weight-related effects on levels of 25-hydroxyvitamin D are not mediated by vitamin D binding protein. Clin Endocrinol (Oxf) 2007;67:259–264.

24Sollid ST, Hutchinson MY, Berg V, Fuskevag OM, Figenschau Y, Thorsby PM, et al: Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D. Eur J Endocrinol 2016;174:445–452.

25Pop LC, Shapses SA, Chang B, Sun W, Wang X: Vitamin D-binding protein in healthy pre- and postmenopausal women: relationship with estradiol concentrations. Endocr Pract 2015;21:936–942.

26Moller UK, Streym S, Jensen LT, Mosekilde L, Schoenmakers I, Nigdikar S, et al: Increased plasma concentrations of vitamin D metabolites and vitamin D binding protein in women using hormonal contraceptives: a cross-sectional study. Nutrients 2013;5:3470–3480.

27Bikle DD, Gee E, Halloran B, Haddad JG: Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest 1984;74:1966–1971.

28Shoukry A, Bdeer Sel A, El-Sokkary RH: Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus. Mol Cell Biochem 2015;408:25–35.

29Jeng L, Yamshchikov AV, Judd SE, Blumberg HM, Martin GS, Ziegler TR, et al: Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009;7:28.

30Ghafouri B, Carlsson A, Holmberg S, Thelin A, Tagesson C: Biomarkers of systemic inflammation in farmers with musculoskeletal disorders; a plasma proteomic study. BMC Musculoskelet Disord 2016;17:206.

31Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al: The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96:53–58.

32Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–1930.

33Chun RF, Peercy BE, Orwoll ES, Nielson CM, Adams JS, Hewison M: Vitamin D and DBP: the free hormone hypothesis revisited. J Steroid Biochem Mol Biol 2014;144(Pt A):132–137.

34Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, et al: An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 1999;96:507–515.

35Zella LA, Shevde NK, Hollis BW, Cooke NE, Pike JW: Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology 2008;149:3656–3667.

36Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, et al: Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 2013;369:1991–2000.

37Santos BR, Mascarenhas LP, Boguszewski MC, Spritzer PM: Variations in the vitamin D-binding protein (DBP) gene are related to lower 25-hydroxyvitamin D levels in healthy girls: a cross-sectional study. Horm Res Paediatr 2013;79:162–168.

38Nielson CM, Jones KS, Chun RF, Jacobs JM, Wang Y, Hewison M, et al: Free 25-hydroxyvitamin D: impact of vitamin D binding protein assays on racialgenotypic associations. J Clin Endocrinol Metab 2016;101:2226–2234.

39Li C, Chen P, Duan X, Wang J, Shu B, Li X, et al: Bioavailable 25(OH)D but not total 25(OH)D is an independent determinant for bone mineral density in Chinese postmenopausal women. EBioMedicine 2017;15:184–192.

40Lauridsen AL, Vestergaard P, Hermann AP, Moller HJ, Mosekilde L, Nexo E: Female premenopausal fracture risk is associated with gc phenotype. J Bone Miner Res 2004;19:875–881.

      Marise Lazaretti-Castro, MD, PhD

      Universidade Federal de São Paulo

      Rua Botucatu 806, Vila Clementino

      São Paulo, SP 04023–062 (Brazil)

      E-Mail [email protected]